Figure 1.

 Most common safety-related events by assessment method among individuals who were reported to have received TCV¹—Navi Mumbai, India, 2018. ¹Typbar-TCV, Bharat Biotech International Limited, India. ²Per administrative reports. ³A total of 2023 children experienced at least 1 AEFI at either time point (48 hours or 7 days following TCV vaccination). At 7 days following vaccination, 172 of 343 children had reported an AEFI at 48 hours as well. ⁴Telephone interviews were conducted among 5605 caregivers of TCV recipients at 48 hours after vaccination. At 7 days following TCV vaccination, 4728 of those caregivers were interviewed again. ⁵Fever was the only AEFI reported among more than 1% of vaccine recipients 7 days following vaccination. Abbreviations: AEFI, adverse events following immunization; TCV, typhoid conjugate vaccine.